Catalyst Wire Dossier Catalyst Wire Dossier

SHR-A1921

· Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for SHR-A1921, covering 2024-01-18 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC [Phase 1, Phase 2]

See pricing